This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Aucubin is an iridoid glycoside that has been found in E. ulmoides with diverse biological activities. Aucubin (0.001-1 µg/ml) dose-dependently inhibits the IgE-stimulated secretion of IL-6 and TNF-alpha by RBL-2H3 mast cells (IC50s = 0.19 and 0.1 µg/ml, respectively). It reduces UVB-induced expression of matrix metalloproteinase-1 (MMP-1) in HS68 human foreskin fibroblasts by 57% when used at a concentration of 0.01 µg/ml. Aucubin (0.01-1 µg/ml) also dose-dependently reduces production of reactive oxygen species (ROS) and malondialdehyde (MDA) levels, a marker of lipid peroxidation. In a mouse model of pulmonary fibrosis induced by bleomycin (Cay-13877), aucubin (5 mg/kg, i.p.) decreases the breathing frequency, increases lung dynamic compliance, alleviates parenchymal fibrotic changes, and reduces expression of TGF-beta1 and alpha-smooth muscle actin (alpha-SMA). Aucubin (5 mg/kg, i.p.) reduces blood glucose levels and lipid peroxidation in the liver and kidneys of rats with diabetes induced by streptozotocin (Cay-13104). It also reduces the number of errors made in a Y-maze and enhances neuronal survival by approximately 7- and 4-fold, respectively, in rats with streptozotocin-induced diabetes.Formal Name: (1S,4aR,5S,7aS)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl beta-D-glucopyranoside. CAS Number: 479-98-1. Molecular Formula: C15H22O9. Formula Weight: 346.3. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 30 mg/ml, DMSO: 30 mg/ml, PBS (pH 7.2): 10 mg/ml. SMILES: OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@](O[C@H]2[C@@](C(CO)=C[C@H]3O)([H])[C@@]3([H])C=CO2)([H])O1. InChi Code: InChI=1S/C15H22O9/c16-4-6-3-8(18)7-1-2-22-14(10(6)7)24-15-13(21)12(20)11(19)9(5-17)23-15/h1-3,7-21H,4-5H2/t7-,8+,9+,10+,11+,12-,13+,14-,15-/m0/s1. InChi Key: RJWJHRPNHPHBRN-FKVJWERZSA-N.
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.
More information